Establishment and characterization of xenograft models of human neuroblastoma bone metastasis

Child's Nervous System

Volumn 28, Issue 12, 2012, Pages 2047-2054

  Zhao, Hongyu ^a   Cai, Weisong ^a   Li, Shuai ^a   Da, Zuke ^a   Sun, Hanxue ^a   Ma, Liang ^a   Lin, Yaoxin ^a   Zhi, Debao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Bone metastasis; Neuroblastoma; Osteolytic response

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ENDOTHELIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE METASTASIS; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL SUSPENSION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROBLASTOMA; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; SINGLE CELL SUSPENSION; TUMOR XENOGRAFT;

ANIMALS; BONE NEOPLASMS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; OSTEOLYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84871192705     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-012-1909-3     Document Type: Article

References (32)

1. Ara T, DeClerck YA (2006) Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25:645-657
2. Bilir A, Erguven M, Yazihan N, Aktas E, Oktem G, Sabanci A (2010) Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in humanneuroblastoma cancer cell line SH-SY5Y. J Neurooncol 100:385-395
3. Carlisle AJ, Lyttle CA, Carlisle RY, Maris JM (2009) CXCR4 expression heterogeneity in neuroblastoma cells due to ligandindependent regulation. Mol Cancer 8:126
4. Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, Thotala DK (2011) GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line. J Neurooncol 104:145-153
5. Dubois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, Haase GM, Black CT, Perez C, Shimada H, Gerbing R, Stram DO, Matthay KK (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 21:181-189
6. Feng C, Zuo Z (2012) Regulatory factor X1-induced downregulation of transforming growth factor β2 transcription in human neuroblastoma cells. J Biol Chem 287:22730-22739
7. Granchi D, Corrias MV, Garaventa A, Baglìo SR, Cangemi G, Carlini B, Paolucci P, Giunti A, Baldini N (2011) Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels. Bone 48:152-159
8. Granchi D, Garaventa A, Amato I, Paolucci P, Baldini N (2006) Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma. Int J Cancer 119:146-151
9. Hua Y, Gorshkov K, Yang Y, Wang W, Zhang N, Hughes DP (2012) Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma. Cancer. doi:10.1002/cncr.27496
10. Kroesen M, Lindau D, Hoogerbrugge P, Adema GJ (2012) Immunocombination therapy for high-risk neuroblastoma. Immunotherapy 4:163-174
11. Li W, Chu Y, Zhang L, Yin L, Li L (2012) Ginsenoside Rg1 prevents SK-N-SH neuroblastoma cell apoptosis induced by supernatant from Aβ(1-40)- stimulated THP-1 monocytes. Brain Res Bull 88:501-506
12. Ma M, Ye JY, Deng R, Dee CM, Chan GC (2011) Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/ CXCR4 and SDF-1/CXCR7 signaling. Cancer Lett 312:1-10
13. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106-2120
14. Matthay KK, George RE, Yu AL (2012) Promising therapeutic targets in neuroblastoma. Clin Cancer Res 18:2740-2753
15. Meier R, Mühlethaler-Mottet A, Flahaut M, Coulon A, Fusco C, Louache F, Auderset K, Bourloud KB, Daudigeos E, Ruegg C, Vassal G, Gross N, Joseph JM (2007) The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion. PLoS One 2:e1016
16. Owens C, Irwin M (2012) Neuroblastoma: The impact of biology and cooperation leading to personalized treatments. Crit Rev Clin Lab Sci 49:85-115
17. Park JR, Eggert A, Caron H (2008) Neuroblastoma: Biology, prognosis, and treatment. Pediatr Clin North Am 55:97-120
18. Patel LR, Camacho DF, Shiozawa Y, Pienta KJ, Taichman RS (2011) Mechanisms of cancer cell metastasis to the bone: A multistep process. Future Oncol 7:1285-1297
19. Peng H, Sohara Y, Moats RA, Nelson MD Jr, Groshen SG, Ye W, Reynolds CP, DeClerck YA (2007) The activity of zoledronic acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation. Cancer Res 67:9346-9355
20. Poretti A, Grotzer MA (2012) Neuroblastoma with spinal cord compression: Is there an emergency treatment of choice? Dev Med Child Neurol 54:297-298
21. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 351:195-196
22. Sartelet H, Durrieu L, Fontaine F, Nyalendo C, Haddad E (2012) Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice. In Vivo 26:19-29
23. Sharp SE, Gelfand MJ, Shulkin BL (2011) Pediatrics: Diagnosis of neuroblastoma. Semin Nucl Med 41:345-353
24. Sohara Y, Shimada H, DeClerck YA (2005) Mechanisms of bone invasion and metastasis in human neuroblastoma. Cancer Lett 228:203-209
25. Sohara Y, Shimada H, Scadeng M, Pollack H, Yamada S, Ye W, Reynolds CP, DeClerck YA (2003) Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate. Cancer Res 63:3026-3031
26. Sorrentino S, Rosanda C, Parodi S, Rita Gigliotti A, Pasino M, Defferrari R, Paolo Tonini G, De Bernardi B (2012) Cytomorphologic evaluation of bone marrow in infants with disseminated neuroblastoma. J Pediatr Hematol Oncol 34:154-158
27. Sun W, Modak S (2012) Emerging treatment options for the treatment of neuroblastoma: Potential role of perifosine. Onco Targets Ther 5:21-29
28. Suva LJ, Washam C, Nicholas RW, Griffin RJ (2011) Bone metastasis: Mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7:208-218
29. Ishola TA, Chung DH (2007) Neuroblastoma. Surg Oncol 16:149-156
30. van Golen CM, Schwab TS, Kim B, Soules ME, Su Oh S, Fung K, van Golen KL, Feldman EL (2006) Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. Cancer Res 66:6570-6578
31. Yang S, Zheng J, Ma Y, Zhu H, Xu T, Dong K, Xiao X (2012) Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy. Oncol Rep 28:186-192
32. Zhang L, Yeger H, Das B, Irwin MS, Baruchel S (2007) Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia 9:36-46